Evolution of synchronous female bilateral breast cancers and response to treatment.
Saved in:
| Title: | Evolution of synchronous female bilateral breast cancers and response to treatment. |
|---|---|
| Authors: | Hamy AS; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France.; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France., Abécassis J; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.; INRIA, Université Paris-Saclay, CEA, Palaiseau, France., Driouch K; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France., Darrigues L; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France., Vandenbogaert M; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France.; INSERM U830, Institut Curie, PSL University, Paris, France., Laurent C; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France., Zaccarini F; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France., Sadacca B; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.; INSERM U830, Institut Curie, PSL University, Paris, France., Delomenie M; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France., Laas E; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France., Mariani O; Biological Resource Center, Department of Pathology, Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL University, Paris, France., Lam T; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France.; Department of Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland., Grandal B; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France., Laé M; Biological Resource Center, Department of Pathology, Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL University, Paris, France.; Department of Pathology, Centre Henri Becquerel, INSERM U1245, UNIROUEN, University of Normandie, Rouen, France., Bieche I; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France.; INSERM U1016, Faculty of Pharmaceutical and Biological Sciences, Université de Paris Cité, Paris, France., Vacher S; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France., Pierga JY; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France., Brain E; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France., Vallot C; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France.; CNRS UMR3244, Institut Curie, PSL University, Paris, France., Hotton J; Department of Surgical Oncology, Institut Godinot, Reims, France., Richer W; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France.; Translational Immunotherapy Team, INSERM U932, Institut Curie, PSL University, Paris, France., Rocha D; Translational Immunotherapy Team, INSERM U932, Institut Curie, PSL University, Paris, France., Tariq Z; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France., Becette V; Biological Resource Center, Department of Pathology, Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL University, Paris, France., Meseure D; Department of Diagnostic and Theranostic Medicine, Institut Curie, University Paris-Sciences et Lettres, Paris, France., Lesage L; Department of Diagnostic and Theranostic Medicine, Institut Curie, University Paris-Sciences et Lettres, Paris, France., Vincent-Salomon A; Department of Diagnostic and Theranostic Medicine, Institut Curie, University Paris-Sciences et Lettres, Paris, France., Filmann N; German Breast Group, Neu-Isenburg, Germany., Furlanetto J; German Breast Group, Neu-Isenburg, Germany., Loibl S; German Breast Group, Neu-Isenburg, Germany.; Centre for Haematology and Oncology/Bethanien, Frankfurt am Main, Germany., Dumas E; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France., Waterfall JJ; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France. joshua.waterfall@curie.fr.; INSERM U830, Institut Curie, PSL University, Paris, France. joshua.waterfall@curie.fr., Reyal F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France. fabien.reyal@curie.fr.; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France. fabien.reyal@curie.fr. |
| Source: | Nature medicine [Nat Med] 2023 Mar; Vol. 29 (3), pp. 646-655. Date of Electronic Publication: 2023 Mar 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36879128 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evolution of synchronous female bilateral breast cancers and response to treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hamy+AS%22">Hamy AS</searchLink>; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France.; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Abécassis+J%22">Abécassis J</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.; INRIA, Université Paris-Saclay, CEA, Palaiseau, France.<br /><searchLink fieldCode="AU" term="%22Driouch+K%22">Driouch K</searchLink>; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Darrigues+L%22">Darrigues L</searchLink>; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vandenbogaert+M%22">Vandenbogaert M</searchLink>; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France.; INSERM U830, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Laurent+C%22">Laurent C</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Zaccarini+F%22">Zaccarini F</searchLink>; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sadacca+B%22">Sadacca B</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.; INSERM U830, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Delomenie+M%22">Delomenie M</searchLink>; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Laas+E%22">Laas E</searchLink>; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mariani+O%22">Mariani O</searchLink>; Biological Resource Center, Department of Pathology, Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lam+T%22">Lam T</searchLink>; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France.; Department of Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Grandal+B%22">Grandal B</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Laé+M%22">Laé M</searchLink>; Biological Resource Center, Department of Pathology, Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL University, Paris, France.; Department of Pathology, Centre Henri Becquerel, INSERM U1245, UNIROUEN, University of Normandie, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Bieche+I%22">Bieche I</searchLink>; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France.; INSERM U1016, Faculty of Pharmaceutical and Biological Sciences, Université de Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vacher+S%22">Vacher S</searchLink>; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Pierga+JY%22">Pierga JY</searchLink>; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Brain+E%22">Brain E</searchLink>; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vallot+C%22">Vallot C</searchLink>; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France.; CNRS UMR3244, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Hotton+J%22">Hotton J</searchLink>; Department of Surgical Oncology, Institut Godinot, Reims, France.<br /><searchLink fieldCode="AU" term="%22Richer+W%22">Richer W</searchLink>; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France.; Translational Immunotherapy Team, INSERM U932, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rocha+D%22">Rocha D</searchLink>; Translational Immunotherapy Team, INSERM U932, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tariq+Z%22">Tariq Z</searchLink>; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Becette+V%22">Becette V</searchLink>; Biological Resource Center, Department of Pathology, Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Meseure+D%22">Meseure D</searchLink>; Department of Diagnostic and Theranostic Medicine, Institut Curie, University Paris-Sciences et Lettres, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lesage+L%22">Lesage L</searchLink>; Department of Diagnostic and Theranostic Medicine, Institut Curie, University Paris-Sciences et Lettres, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vincent-Salomon+A%22">Vincent-Salomon A</searchLink>; Department of Diagnostic and Theranostic Medicine, Institut Curie, University Paris-Sciences et Lettres, Paris, France.<br /><searchLink fieldCode="AU" term="%22Filmann+N%22">Filmann N</searchLink>; German Breast Group, Neu-Isenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Furlanetto+J%22">Furlanetto J</searchLink>; German Breast Group, Neu-Isenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Loibl+S%22">Loibl S</searchLink>; German Breast Group, Neu-Isenburg, Germany.; Centre for Haematology and Oncology/Bethanien, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Dumas+E%22">Dumas E</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Waterfall+JJ%22">Waterfall JJ</searchLink>; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France. joshua.waterfall@curie.fr.; INSERM U830, Institut Curie, PSL University, Paris, France. joshua.waterfall@curie.fr.<br /><searchLink fieldCode="AU" term="%22Reyal+F%22">Reyal F</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France. fabien.reyal@curie.fr.; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France. fabien.reyal@curie.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2023 Mar; Vol. 29 (3), pp. 646-655. <i>Date of Electronic Publication: </i>2023 Mar 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36879128 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-023-02216-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 646 Titles: – TitleFull: Evolution of synchronous female bilateral breast cancers and response to treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hamy AS – PersonEntity: Name: NameFull: Abécassis J – PersonEntity: Name: NameFull: Driouch K – PersonEntity: Name: NameFull: Darrigues L – PersonEntity: Name: NameFull: Vandenbogaert M – PersonEntity: Name: NameFull: Laurent C – PersonEntity: Name: NameFull: Zaccarini F – PersonEntity: Name: NameFull: Sadacca B – PersonEntity: Name: NameFull: Delomenie M – PersonEntity: Name: NameFull: Laas E – PersonEntity: Name: NameFull: Mariani O – PersonEntity: Name: NameFull: Lam T – PersonEntity: Name: NameFull: Grandal B – PersonEntity: Name: NameFull: Laé M – PersonEntity: Name: NameFull: Bieche I – PersonEntity: Name: NameFull: Vacher S – PersonEntity: Name: NameFull: Pierga JY – PersonEntity: Name: NameFull: Brain E – PersonEntity: Name: NameFull: Vallot C – PersonEntity: Name: NameFull: Hotton J – PersonEntity: Name: NameFull: Richer W – PersonEntity: Name: NameFull: Rocha D – PersonEntity: Name: NameFull: Tariq Z – PersonEntity: Name: NameFull: Becette V – PersonEntity: Name: NameFull: Meseure D – PersonEntity: Name: NameFull: Lesage L – PersonEntity: Name: NameFull: Vincent-Salomon A – PersonEntity: Name: NameFull: Filmann N – PersonEntity: Name: NameFull: Furlanetto J – PersonEntity: Name: NameFull: Loibl S – PersonEntity: Name: NameFull: Dumas E – PersonEntity: Name: NameFull: Waterfall JJ – PersonEntity: Name: NameFull: Reyal F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2023 Mar Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 29 – Type: issue Value: 3 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |